RT Journal Article
SR Electronic
T1 BRAVE-NET: Fully Automated Arterial Brain Vessel Segmentation In Patients with Cerebrovascular Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.08.20057570
DO 10.1101/2020.04.08.20057570
A1 Adam Hilbert
A1 Vince I. Madai
A1 Ela M. Akay
A1 Orhun U. Aydin
A1 Jonas Behland
A1 Jan Sobesky
A1 Ivana Galinovic
A1 Ahmed A. Khalil
A1 Abdel A. Taha
A1 Jens Wuerfel
A1 Petr Dusek
A1 Thoralf Niendorf
A1 Jochen B. Fiebach
A1 Dietmar Frey
A1 Michelle Livne
YR 2020
UL http://medrxiv.org/content/early/2020/04/11/2020.04.08.20057570.abstract
AB Introduction Arterial brain vessel assessment is crucial for the diagnostic process in patients with cerebrovascular disease. Noninvasive neuroimaging techniques such as time-of-flight (TOF) magnetic resonance angiography (MRA) imaging are applied in the clinical routine to depict arteries. They are, however, only visually assessed. Fully automated vessel segmentation integrated into the clinical routine could facilitate the time-critical diagnosis of vessel abnormalities and might facilitate the identification of valuable biomarkers for cerebrovascular events. In the present work, we developed and validated a new deep learning model for vessel segmentation, coined BRAVE-NET, on a large aggregated dataset of patients with cerebrovascular diseases.Methods BRAVE-NET is a multiscale 3-D convolutional neural network (CNN) model developed on a dataset of 264 patients from 3 different studies enrolling patients with cerebrovascular diseases. A context path, dually capturing high- and low-resolution volumes, and deep supervision were implemented. The BRAVE-NET model was compared to a baseline Unet model and variants with only context paths and deep supervision, respectively. The models were developed and validated using high-quality manual labels as ground truth. Next to precision and recall, the performance was assessed quantitatively by Dice coefficient (DSC); average Hausdorff distance (AVD); 95- percentile Hausdorff distance (95HD) and via visual qualitative rating.Results The BRAVE-NET performance surpassed the other models for arterial brain vessel segmentation with a DSC = 0.931, AVD = 0.165 and 95HD = 29.153. The BRAVE-NET model was also the most resistant towards false labelings as revealed by the visual analysis. The performance improvement is primarily attributed to the integration of the multiscaling context path into the 3-D Unet and to a lesser extent to the deep supervision architectural component.Discussion We present a new state-of-the-art of arterial brain vessel segmentation tailored to cerebrovascular pathology. We provide an extensive experimental validation of the model using a large aggregated dataset encompassing a large variability of cerebrovascular disease. The framework provides the technological foundation for improving the clinical workflow and can serve as a biomarker extraction tool in cerebrovascular diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has received funding by the German Federal Ministry of Education and Research through (1) the grant Centre for Stroke Research Berlin and (2) a Go-Bio grant for the research group PREDICTioN2020 (lead: DF).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to data protection laws, the imaging data used in this study cannot be published at the current time point.